GlaxoSmithKline and Novartis have made another admission in a case brought by the ACCC alleging the drug giants made misleading claims in marketing their Voltaren Osteo […]
Competition & Consumer Protection
March 6, 2018 8:07 pm
| Melbourne
related coverage